Novo Nordisk SG&A Expense (TTM) Trends | YCharts

Novo Nordisk A/S (NVO)

46.60 -0.91 (-1.92%) USD | NYSE | Sep 04, 16:00

46.54 -0.06 (-0.13%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NVO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1999. Start Trial.

Date	Value
June 30, 2026	10.12B
March 31, 2026	10.45B
December 31, 2025	10.66B
September 30, 2025	10.84B
June 30, 2025	10.48B
March 31, 2025	9.939B
December 31, 2024	9.764B
September 30, 2024	9.549B
June 30, 2024	9.160B
March 31, 2024	9.090B
December 31, 2023	8.936B
September 30, 2023	8.319B
June 30, 2023	7.971B
March 31, 2023	7.412B
December 31, 2022	7.150B
September 30, 2022	7.051B
June 30, 2022	6.952B
March 31, 2022	6.703B
December 31, 2021	6.510B
September 30, 2021	6.296B
June 30, 2021	6.129B
March 31, 2021	5.900B
December 31, 2020	5.668B
September 30, 2020	5.508B
June 30, 2020	5.373B

Date	Value
March 31, 2020	5.427B
December 31, 2019	5.367B
September 30, 2019	5.299B
June 30, 2019	5.250B
March 31, 2019	5.251B
December 31, 2018	5.263B
September 30, 2018	5.223B
June 30, 2018	5.133B
March 31, 2018	4.992B
December 31, 2017	4.888B
September 30, 2017	4.714B
June 30, 2017	4.727B
March 31, 2017	4.774B
December 31, 2016	4.801B
September 30, 2016	4.836B
June 30, 2016	4.833B
March 31, 2016	4.853B
December 31, 2015	4.779B
September 30, 2015	4.729B
June 30, 2015	4.755B
March 31, 2015	4.728B
December 31, 2014	4.753B
September 30, 2014	4.832B
June 30, 2014	4.756B
March 31, 2014	4.753B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

AstraZeneca PLC	585.31M
Johnson & Johnson	25.14B
Eli Lilly & Co.	12.24B
Merck & Co., Inc.	11.14B
Novartis AG	13.14B